Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
MEDX
#7175
Horizon Kinetics Medical ETF
33.5
3
USD
-0.68%
Sector:
Financial
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.68%
Monthly Change
+0.69%
6 month change
+7.09%
Year Change
+33.21%
Previous Close
33.7
6
Open
33.5
3
Bid
Ask
Low
33.5
3
High
33.5
3
Volume
1
Markets
US Stock Market
Financial
MEDX
Open full chart
Top holdings
Market Value
Shares
Weight %
LLY
Eli Lilly & Co
3.46 M
3 218.00
18.25%
ABBV
AbbVie Inc
1.68 M
7 356.00
8.87%
US BANK MMDA - USBGFS 7
1.40 M
1.40 M
7.42%
NVS
Novartis AG
1.27 M
9 194.00
6.69%
AZN
AstraZeneca PLC
1.01 M
10.99 K
5.33%
JNJ
Johnson & Johnson
952.38 K
4 602.00
5.03%
IONS
Ionis Pharmaceuticals Inc
945.52 K
11.95 K
4.99%
ALNY
Alnylam Pharmaceuticals Inc
944.82 K
2 376.00
4.99%
BMY
Bristol-Myers Squibb Co
865.84 K
16.05 K
4.57%
AMGN
Amgen Inc
739.72 K
2 260.00
3.90%
MRK
Merck & Co Inc
677.45 K
6 436.00
3.58%
PFE
Pfizer Inc
618.12 K
24.82 K
3.26%
Alkermes PLC
617.41 K
22.07 K
3.26%
REGN
Regeneron Pharmaceuticals Inc
532.59 K
690.00
2.81%
CRISPR Therapeutics AG
530.38 K
10.11 K
2.80%
GSK
GSK PLC
529.24 K
10.79 K
2.79%
BIIB
Biogen Inc
525.86 K
2 988.00
2.78%
BEAM
Beam Therapeutics Inc
254.86 K
9 194.00
1.35%
VNDA
Vanda Pharmaceuticals Inc
218.95 K
24.82 K
1.16%
GALT
Galectin Therapeutics Inc
214.17 K
51.48 K
1.13%
News
Medmix FY25 revenue falls, dividend cut 80%; shares down 17%
Medmix FY 2025 slides: margins surge 90bps as revenue falls 7.4%
Earnings call transcript: Medmix sees margin growth amid revenue dip in H2 2025
Medical ETF (MEDX) Touches New 52-Week High
Stifel initiates coverage on Medmix stock with Buy rating, CHF14.50 target
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
Horizon Kinetics Q3 2025 Commentary (HKHC)
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data